BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25498084)

  • 1. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.
    Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Kitahara M; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Onishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
    Transplant Proc; 2014 Dec; 46(10):3523-35. PubMed ID: 25498084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report.
    Yamada N; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Okada N; Mizuta K
    Transplant Proc; 2012 Apr; 44(3):810-3. PubMed ID: 22483502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.
    Sebagh M; Azoulay D; Roche B; Hoti E; Karam V; Teicher E; Bonhomme-Faivre L; Saliba F; Duclos-Vallée JC; Samuel D
    Liver Transpl; 2011 Jul; 17(7):798-808. PubMed ID: 21351239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
    Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
    Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report.
    Nakanuma S; Miyashita T; Hayashi H; Tajima H; Takamura H; Tsukada T; Okamoto K; Sakai S; Makino I; Kinoshita J; Nakamura K; Oyama K; Inokuchi M; Nakagawara H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Exp Ther Med; 2015 Apr; 9(4):1119-1124. PubMed ID: 25780397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable ascites without mechanical vascular obstruction after orthotopic liver transplantation: etiology and clinical outcome of sinusoidal obstruction syndrome.
    Kitajima K; Vaillant JC; Charlotte F; Eyraud D; Hannoun L
    Clin Transplant; 2010; 24(1):139-48. PubMed ID: 19222508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Devastating outflow obstruction after pediatric split liver transplantation.
    Sakamoto S; Nakazawa A; Shigeta T; Uchida H; Kanazawa H; Fukuda A; Karaki C; Nosaka S; Kasahara M
    Pediatr Transplant; 2013 Feb; 17(1):E25-8. PubMed ID: 22805415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.
    Sebagh M; Debette M; Samuel D; Emile JF; Falissard B; Cailliez V; Shouval D; Bismuth H; Reynès M
    Hepatology; 1999 Nov; 30(5):1144-50. PubMed ID: 10534334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
    Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
    Coutsouvelis J; Kirkpatrick CM; Dooley M; Spencer A; Kennedy G; Chau M; Huang G; Doocey R; Copeland TS; Do L; Bardy P; Kerridge I; Cole T; Fraser C; Perera T; Larsen SR; Mason K; O'Brien TA; Shaw PJ; Teague L; Butler A; Watson AM; Ramachandran S; Marsh J; Khan Z; Hamad N
    Transplant Cell Ther; 2023 Jun; 29(6):383.e1-383.e10. PubMed ID: 36934993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Corbacioglu S; Jabbour EJ; Mohty M
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].
    Kikuta A
    Rinsho Ketsueki; 2021; 62(8):1256-1264. PubMed ID: 34497214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
    Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
    Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
    Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.
    Putta S; Young BA; Levine JE; Reshef R; Nakamura R; Strouse C; Perales MA; Howard A; Pine P; Shi J; Zhang P; Ho VT; Saber W
    Transplant Cell Ther; 2023 Mar; 29(3):166.e1-166.e10. PubMed ID: 36574581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
    Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.